Indraprastha Medical Corporation Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹159
- Today's High:
- ₹171.95
- Open Price:
- ₹168.65
- 52W Low:
- ₹60.3
- 52W High:
- ₹176.2
- Prev. Close:
- ₹167
- Volume:
- 26237
Company Statistics
- Market Cap.:
- ₹4.57 billion
- Book Value:
- 29.213
- Revenue TTM:
- ₹8.31 billion
- Operating Margin TTM:
- 6.55%
- Gross Profit TTM:
- ₹4.46 billion
- Profit Margin:
- 5.25%
- Return on Assets TTM:
- 7.81%
- Return on Equity TTM:
- 17.05%
Company Profile
Indraprastha Medical Corporation Limited had its IPO on under the ticker symbol 532150.
The company operates in the Healthcare sector and Hospitals industry. Indraprastha Medical Corporation Limited has a staff strength of 3,215 employees.
Stock update
Shares of Indraprastha Medical Corporation Limited opened at ₹168.65 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹159 - ₹171.95, and closed at ₹159.7.
This is a -4.37% slip from the previous day's closing price.
A total volume of 26,237 shares were traded at the close of the day’s session.
In the last one week, shares of Indraprastha Medical Corporation Limited have slipped by -11.43%.
Indraprastha Medical Corporation Limited's Key Ratios
Indraprastha Medical Corporation Limited has a market cap of ₹4.57 billion, indicating a price to book ratio of 1.8449 and a price to sales ratio of 0.7103.
In the last 12-months Indraprastha Medical Corporation Limited’s revenue was ₹8.31 billion with a gross profit of ₹4.46 billion and an EBITDA of ₹843.53 million. The EBITDA ratio measures Indraprastha Medical Corporation Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Indraprastha Medical Corporation Limited’s operating margin was 6.55% while its return on assets stood at 7.81% with a return of equity of 17.05%.
In Q3, Indraprastha Medical Corporation Limited’s quarterly earnings growth was a negative -9% while revenue growth was a positive 0%.
Indraprastha Medical Corporation Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 46.0185
- PEG
Its diluted EPS in the last 12-months stands at ₹4.759 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Indraprastha Medical Corporation Limited’s profitability.
Indraprastha Medical Corporation Limited stock is trading at a EV to sales ratio of 0.6683 and a EV to EBITDA ratio of 19.98. Its price to sales ratio in the trailing 12-months stood at 0.7103.
Indraprastha Medical Corporation Limited stock pays annual dividends of ₹1.8 per share, indicating a yield of 3.58% and a payout ratio of 148.15%.
Balance sheet and cash flow metrics
- Total Assets
- ₹5.55 billion
- Total Liabilities
- ₹1.30 billion
- Operating Cash Flow
- ₹-1079100000.00
- Capital Expenditure
- ₹445.80 million
- Dividend Payout Ratio
- 148.15%
Indraprastha Medical Corporation Limited ended 2024 with ₹5.55 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹5.55 billion while shareholder equity stood at ₹3.79 billion.
Indraprastha Medical Corporation Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹1.30 billion in other current liabilities, 916700000.00 in common stock, ₹2.88 billion in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹1.29 billion and cash and short-term investments were ₹1.36 billion. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.
Indraprastha Medical Corporation Limited’s total current assets stands at ₹2.23 billion while long-term investments were ₹0 and short-term investments were ₹67.80 million. Its net receivables were ₹682.40 million compared to accounts payable of ₹0 and inventory worth ₹84.50 million.
In 2024, Indraprastha Medical Corporation Limited's operating cash flow was ₹-1079100000.00 while its capital expenditure stood at ₹445.80 million.
Comparatively, Indraprastha Medical Corporation Limited paid ₹1.48 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹159.7
- 52-Week High
- ₹176.2
- 52-Week Low
- ₹60.3
- Analyst Target Price
- ₹
Indraprastha Medical Corporation Limited stock is currently trading at ₹159.7 per share. It touched a 52-week high of ₹176.2 and a 52-week low of ₹176.2. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹139.22 and 200-day moving average was ₹98.08 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 6009.9% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Indraprastha Medical Corporation Limited
Similar Industry Stocks (Hospitals)
Most Active
Top Gainers
Top Losers
About
Indraprastha Medical Corporation Limited provides hospital services in India. It offers services primarily in the areas of anesthesiology, advanced pediatrics, bone marrow transplant, cosmetic and plastic surgery, dental clinic, dermatology, elder care department, neonatology, general and advance laparoscopic surgery, pediatric urology and pediatric surgery, endocrinology, ear, nose, throat, fetal medicine, gastroenterology and GI surgery, gynecology and obstetrics, heart institutes, infertility care, critical care, bariatric, cancer, emergency, nephrology, neurosciences, orthopedics, robotic surgery, spine, transplant, internal medicine, nuclear medicine, ophthalmology, psychiatry and clinical psychology, radiology/radio diagnosis, rheumatology, urology and andrology, and vascular and endovascular surgery. The company also operates cosmetic and pain clinic, and wellness center, as well as Apollo 24/7 app; and offers services in the areas of sugar, dietetics and clinical nutrition, hyperbaric oxygen therapy, laboratory services, physiotherapy and rehabilitation, and transfusion medicine. Indraprastha Medical Corporation Limited was incorporated in 1988 and is based in New Delhi, India.